Featured Research

from universities, journals, and other organizations

Radiologists And Engineers Develop A Modified Catheter To Reduce Contrast Material Injuries

Date:
September 21, 2009
Source:
American Roentgen Ray Society
Summary:
Though rare, IV contrast material administration can sometimes result in patient injury. However researchers have developed a modified catheter that may prevent such events from occurring, according to a new study.

Though rare, IV contrast material administration can sometimes result in patient injury. However researchers have developed a modified catheter that may prevent such events from occurring, according to a new study.

The force of the contrast material exiting the end hole of a standard catheter is what is believed to be one of the main causes of patient injury. For this study, performed at Duke University Medical Center, modified catheters with side holes and slits were developed. An imaging system was used to compare the fluid flow from a modified catheter and a standard catheter.

"We found a less pronounced amount of contrast material exited the end holes of the modified catheter as compared with the standard end-hole-only catheter," said Rendon C. Nelson, MD, senior author of the study. "Numeric calculations showed that the addition of side holes or slits resulted in a nine to 30 percent reduction of the velocity of contrast material exiting the end hole of the catheter. And we saw more of a cloud like dispersal rather than a jet," said Dr. Nelson.

"The rate at which these injuries occur varies from practice to practice. We typically have 14-15 patients per month who suffer from them. Normally the injuries we see are mild, including pain and swelling at the injection site, however they can be more severe," he said.

"As our study suggests, the development of a modified catheter that decreases the jet like phenomenon seen with a standard-end-hole catheter could improve patient safety and decrease the likelihood of injury," said Dr. Nelson.

This study appears in the October issue of the American Journal of Roentgenology.


Story Source:

The above story is based on materials provided by American Roentgen Ray Society. Note: Materials may be edited for content and length.


Cite This Page:

American Roentgen Ray Society. "Radiologists And Engineers Develop A Modified Catheter To Reduce Contrast Material Injuries." ScienceDaily. ScienceDaily, 21 September 2009. <www.sciencedaily.com/releases/2009/09/090921075509.htm>.
American Roentgen Ray Society. (2009, September 21). Radiologists And Engineers Develop A Modified Catheter To Reduce Contrast Material Injuries. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2009/09/090921075509.htm
American Roentgen Ray Society. "Radiologists And Engineers Develop A Modified Catheter To Reduce Contrast Material Injuries." ScienceDaily. www.sciencedaily.com/releases/2009/09/090921075509.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins